Non-vitamin K antagonist oral anticoagulants (NOACs) have appeared as a therapeutic alternative to vitamin K antagonists (VKAs). NOACs introduction has changed oral anticoagulation. They are clinically indicated for the prevention of thromboembolic phenomena in patients with non-valvular atrial fibrillation and for the primary and secondary prevention of venous thromboembolism, specifically deep vein thrombosis...
Background: Nowadays there is well-established evidence that the existence of a Helicobacter pylori infection is associated with the occurrence of peptic ulcer. Eradication therapies lead to high rates of ulcer healing and lower rates of recurrences. Objective: To characterize the therapeutic regimens for diagnosed peptic ulcer in clinical practice and/or in patients exposed to eradication therapy even without ...